PURPOSE To provide evidence-based recommendations to practicing clinicians on
management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An …

Lung cancer is the most commonly diagnosed cancer and biggest cause of cancer mortality
worldwide with non-small cell lung cancer (NSCLC) accounting for most cases …

Purpose Radiation therapy is a critical component in the care of patients with non–small-cell
lung cancer (NSCLC), yet cardiac injury after treatment is a significant concern. Therefore …

Cancer remains a major cause of death globally. Given its relapsing and fatal features,
curing cancer seems to be something hardly possible for the majority of patients. In view of …

Radiotherapy remains a major treatment modality for cancer types such as non-small cell
lung carcinoma (or NSCLC). To enhance treatment efficacy at a given radiation dose …

Selective killing of cancer cells while minimizing damage to healthy tissues is the goal of
clinical radiation therapy. This therapeutic ratio can be improved by image-guided radiation …

Until the advent of immune checkpoint inhibitors (ICIs), definitive radiotherapy (RT)
concurrently with chemotherapy was recommended for unresectable, locally advanced non …

Purpose The heart receives high radiation doses during radiation therapy of advanced-
stage lung cancer. We have explored associations between overall survival, cardiac …

Materials and methods PubMed and EMBASE were searched using the following keywords:
locally advanced non-small cell lung cancer, unresectable non-small cell lung cancer …

Background To evaluate spot-scanning proton arc therapy (SPArc) and multi-field robust
optimized intensity modulated proton therapy (RO-IMPT) in treating stage III non-small-cell …